Amorsa Therapeutics

Amorsa Therapeutics is a neuropharmaceutical company pioneering the development and commercialization of breakthrough treatments for psychiatric disorders, including treatment-resistant depression, post-traumatic stress disorder, and obsessive-compulsive disorder. Founded in 2013, Amorsa has assembled a leadership team with extensive experience in building several successful life science companies and a strong track record in developing novel therapeutic approaches.